No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Maxim Group Maintains Mesoblast(MESO.US) With Buy Rating, Maintains Target Price $30
Maxim Group Maintains Mesoblast(MESO.US) With Buy Rating, Raises Target Price to $30
Piper Sandler Maintains Mesoblast(MESO.US) With Buy Rating, Raises Target Price to $15
US Steel Issues Weak Q4 Outlook, Joins Novo Nordisk And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Why FedEx Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
ISCT Hails Landmark US FDA Approval of RYONCIL as Major Milestone for MSC Field
Unlock the Full List